Asen Bagashev

2.6k total citations
27 papers, 685 citations indexed

About

Asen Bagashev is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Asen Bagashev has authored 27 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Asen Bagashev's work include CAR-T cell therapy research (8 papers), Acute Lymphoblastic Leukemia research (7 papers) and RNA Research and Splicing (7 papers). Asen Bagashev is often cited by papers focused on CAR-T cell therapy research (8 papers), Acute Lymphoblastic Leukemia research (7 papers) and RNA Research and Splicing (7 papers). Asen Bagashev collaborates with scholars based in United States, Canada and Netherlands. Asen Bagashev's co-authors include Bassel E. Sawaya, Ruma Mukerjee, J. Robert Chang, Tinatin Chabrashvili, Kathleen E. Sullivan, Kelly Maurer, Mohammad Ghafouri, Zhe Zhang, Susan Coffin and Jordan S. Orange and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Asen Bagashev

26 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Asen Bagashev United States 15 300 178 170 123 105 27 685
Cristina Sorino Italy 13 248 0.8× 262 1.5× 73 0.4× 88 0.7× 96 0.9× 22 615
Nanhong Tang China 16 440 1.5× 204 1.1× 199 1.2× 191 1.6× 126 1.2× 53 955
J. Robert Chang United States 7 201 0.7× 95 0.5× 130 0.8× 61 0.5× 64 0.6× 12 538
José M. Martinez-Navío United States 15 278 0.9× 269 1.5× 211 1.2× 189 1.5× 186 1.8× 25 894
Harold Oliva Spain 13 184 0.6× 80 0.4× 329 1.9× 117 1.0× 70 0.7× 19 689
Lisa Hanson United States 7 159 0.5× 128 0.7× 190 1.1× 64 0.5× 36 0.3× 8 503
S. Bar‐Yehuda Israel 14 430 1.4× 31 0.2× 172 1.0× 180 1.5× 97 0.9× 19 1.1k
Rachel A. Cleary United States 10 203 0.7× 217 1.2× 139 0.8× 50 0.4× 51 0.5× 13 571
Marina Morel France 13 377 1.3× 405 2.3× 206 1.2× 94 0.8× 147 1.4× 19 843
Mariacristina De Luca Italy 10 347 1.2× 74 0.4× 271 1.6× 35 0.3× 91 0.9× 13 697

Countries citing papers authored by Asen Bagashev

Since Specialization
Citations

This map shows the geographic impact of Asen Bagashev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asen Bagashev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asen Bagashev more than expected).

Fields of papers citing papers by Asen Bagashev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asen Bagashev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asen Bagashev. The network helps show where Asen Bagashev may publish in the future.

Co-authorship network of co-authors of Asen Bagashev

This figure shows the co-authorship network connecting the top 25 collaborators of Asen Bagashev. A scholar is included among the top collaborators of Asen Bagashev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asen Bagashev. Asen Bagashev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Claudia, et al.. (2025). Novel In Vivo CAR platform for autoimmune disease therapy. Blood. 146(Supplement 1). 4131–4131.
2.
Niswander, Lisa M, Asen Bagashev, Joseph P. Loftus, et al.. (2024). Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia. Leukemia. 39(3). 555–567. 3 indexed citations
3.
Santerre, Maryline, Charles Allen, Carmen Merali, et al.. (2022). HIV-1 gp120 Impairs Spatial Memory Through Cyclic AMP Response Element-Binding Protein. Frontiers in Aging Neuroscience. 14. 811481–811481. 2 indexed citations
4.
5.
Bagashev, Asen, Joseph P. Loftus, Gerald Wertheim, et al.. (2021). Alisertib Synergistically Strengthens the Anti-Leukemia Activity of Venetoclax in TCF3-Hlf B-ALL. Blood. 138(Supplement 1). 705–705. 2 indexed citations
6.
Hurtz, Christian, Gerald Wertheim, Joseph P. Loftus, et al.. (2020). Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL. Journal of Clinical Investigation. 130(7). 3637–3653. 32 indexed citations
7.
Loftus, Joseph P., Patrick A. Brown, Lisa M Niswander, et al.. (2020). Combinatorial efficacy of entospletinib and chemotherapy in patient-derived xenograft models of infant acute lymphoblastic leukemia. Haematologica. 106(4). 1067–1078. 18 indexed citations
8.
Santerre, Maryline, et al.. (2018). HIV-1 Tat protein promotes neuronal dysregulation by inhibiting E2F transcription factor 3 (E2F3). Journal of Biological Chemistry. 294(10). 3618–3633. 22 indexed citations
9.
Black, Kathryn L., Ammar S. Naqvi, Mukta Asnani, et al.. (2018). Aberrant splicing in B-cell acute lymphoblastic leukemia. Nucleic Acids Research. 46(2). 1043–1043. 37 indexed citations
10.
Bagashev, Asen, Elena Sotillo, Chih-Hang Anthony Tang, et al.. (2018). CD19 Alterations Emerging after CD19-Directed Immunotherapy Cause Retention of the Misfolded Protein in the Endoplasmic Reticulum. Molecular and Cellular Biology. 38(21). 48 indexed citations
11.
Bagashev, Asen, Ruma Mukerjee, Maryline Santerre, et al.. (2014). Involvement of miR-196a in HIV-associated neurocognitive disorders. APOPTOSIS. 19(8). 1202–1214. 14 indexed citations
12.
Bagashev, Asen, Shongshan Fan, Ruma Mukerjee, et al.. (2013). Cdk9 phosphorylates Pirh2 protein and prevents degradation of p53 protein. Cell Cycle. 12(10). 1569–1577. 17 indexed citations
13.
Mukerjee, Ruma, J. Robert Chang, Luis Del Valle, et al.. (2013). Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders.. Journal of Biological Chemistry. 288(39). 28310–28310. 4 indexed citations
14.
Bagashev, Asen & Bassel E. Sawaya. (2013). Roles and functions of HIV-1 Tat protein in the CNS: an overview. Virology Journal. 10(1). 358–358. 96 indexed citations
15.
Chang, J. Robert, Ruma Mukerjee, Asen Bagashev, et al.. (2013). HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs.. Journal of Biological Chemistry. 288(12). 8564–8564. 1 indexed citations
16.
Mukerjee, Ruma, J. Robert Chang, Luis Del Valle, et al.. (2011). Deregulation of microRNAs by HIV-1 Vpr Protein Leads to the Development of Neurocognitive Disorders. Journal of Biological Chemistry. 286(40). 34976–34985. 36 indexed citations
17.
Chang, J. Robert, Ruma Mukerjee, Asen Bagashev, et al.. (2011). HIV-1 Tat Protein Promotes Neuronal Dysfunction through Disruption of MicroRNAs. Journal of Biological Chemistry. 286(47). 41125–41134. 65 indexed citations
18.
Chang, J. Robert, Mohammad Ghafouri, Ruma Mukerjee, et al.. (2011). Role of p53 in Neurodegenerative Diseases. Neurodegenerative Diseases. 9(2). 68–80. 119 indexed citations
19.
Bagashev, Asen, Michael C. Fitzgerald, David F. LaRosa, et al.. (2010). Leucine-Rich Repeat (in Flightless I) Interacting Protein-1 Regulates a Rapid Type I Interferon Response. Journal of Interferon & Cytokine Research. 30(11). 843–852. 15 indexed citations
20.
Coffin, Susan, Kelly Maurer, Asen Bagashev, et al.. (2009). Immune dysregulation in severe influenza. Journal of Leukocyte Biology. 85(6). 1036–1043. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026